IFNG and tuberculosis: Approximately 5% of infected, immunocompetent individuals will develop clinical TB within two years of infection and may exclude the latency phase (approximately 95% of infected individuals), which is characterized by a positive tuberculin skin test (TST) and/or interferon-gamma (IFN-γ) release assay (IGRA) in the absence of clinical symptoms [14,35,36].